SCHEMBL25754049

SCHEMBL25754049

COc1c(NC(=O)OC(C)(C)C)ccn2ncc(C#N)c12

nearest known ligand 0.40

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
RET P07949 16/20 0.40
MAP2K1 Q02750 1/20 0.38
TTK P33981 1/20 0.38
EGLN2 Q96KS0 1/20 0.37
AR P10275 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25757534 0.84 EGLN2 (0.34) RETTTKEGLN2AR
SCHEMBL30895110 0.84 DGAT1 (0.35)
SCHEMBL30895038 0.84 ITGA4 (0.36)
SCHEMBL25757843 0.83 PCSK9 (0.33) RETTTKEGLN2AR
SCHEMBL25757793 0.83 NR1I2 (0.34)
SCHEMBL30895044 0.82 PCSK9 (0.36)
SCHEMBL25757792 0.82 ATR (0.35)
SCHEMBL25757841 0.82 ATR (0.35)
SCHEMBL25757107 0.82 ATR (0.42)
SCHEMBL25757842 0.81 IDO1 (0.37)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118401516-A TYK2 inhibitors, compositions and methods thereof 凌科药业(杭州)有限公司 2024-07-26 CN disclosed
WO-2023109954-A1 TYK2 INHIBITORS AND COMPOSITIONS AND METHODS THEREOF LYNK PHARMACEUTICALS CO. LTD. (CN) 2023-06-22 WO disclosed